FDA Inspection 1311440 — Jeffrey M. Mangel, M.D.
The FDA completed an inspection of Jeffrey M. Mangel, M.D. on Apr 3, 2026 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Cleveland, OH (United States)
Additional details
Clinical Investigator (CI)